Verastem reports $87.9M cash; secures $30M preferred stock and $15M loan for pipeline

Verastem, Inc.

Preliminary unaudited cash and short-term investments of $87.9M as of Dec 31, 2022.
Closed $30M initial tranche of $60M private placement of Series B Convertible Preferred Stock with BVF.
Eligible to draw additional $15M Term B Loan from Oxford Finance upon milestone.
2023 catalysts: initiate confirmatory LGSOC study; initial data from RAMP 203/204 NSCLC trials.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.